10 Best Healthcare Penny Stocks to Buy According to Analysts

7. OPKO Health, Inc. (NASDAQ:OPK)

Stock Price as of June 27: $1.32

Analyst Upside Potential as of June 27: 108.33%

Number of Hedge Fund Holders as of Q1 2025: 26

OPKO Health, Inc. (NASDAQ:OPK) is one of the 10 best healthcare penny stocks to buy according to analysts. On June 25, the company, in partnership with Entera Bio Ltd., announced that new data for their investigational oral OPK-88006 tablet treatment has been selected for presentation at ENDO 2025.

ENDO 2025 is the 2025 chapter of the Endocrine Society’s annual meeting. OPKO will use the occasion to present the medication (OPK-88006) that targets indications like obesity, metabolic disorders, and fibrotic disorders. The drug is being developed as a proprietary novel dual agonist GLP-1/glucagon peptide. It is intended as a once-daily tablet treatment and also as a weekly subcutaneous injection for patients with obesity, metabolic, and fibrotic disorders. The presentation will feature new in vivo data demonstrating the drug’s pharmacologic effects and pharmacokinetic profile.

According to Miranda Toledano, CEO of Entera, oral peptides are rare in metabolic therapy. Therefore, having both tablet and injectable formats could allow for tailored induction and maintenance regimens. The once-daily tablet may offer simpler titration and tolerability benefits, prioritizing durable, sustainable weight loss to help prevent comorbidities such as severe fatty liver disease and sleep apnea.

OPKO Health, Inc. (NASDAQ:OPK) is a diversified healthcare company. It develops and commercializes pharmaceuticals, diagnostics, and multispecific antibody therapies for serious diseases like cancer, infectious diseases, and metabolic disorders. Its key businesses include BioReference Health, one of the largest US clinical laboratories, and ModeX Therapeutics, which focuses on next-generation immunotherapies.